E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/24/2006 in the Prospect News Biotech Daily and Prospect News PIPE Daily.

New Issue: Norwood Abbey sells $3 million one-year convertible note

By Sheri Kasprzak

New York, April 24 - Norwood Abbey Ltd. said it has wrapped a private placement for $3 million.

The company issued a 12% note to a U.S.-based institutional investor.

The note is due in one year and is convertible into common shares at A$0.305 each.

The investor received options for 3,963,012 shares, exercisable at A$0.35 each through April 10, 2010.

Based in Victoria, Australia, Norwood Abbey develops products used in laser eye surgery and other optical procedures.

Issuer:Norwood Abbey Ltd.
Issue:Convertible note
Amount:$3 million
Maturity:One year
Coupon:12%
Price:Par
Yield:12%
Conversion price:A$0.305
Options:For 3,963,012 shares
Options expiration:April 10, 2010
Options strike price:A$0.35
Settlement date:April 24
Stock symbol:Australia: NAL
Stock price:A$0.34 at close April 24

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.